EN
Instrument Fundamentals
| Date | Close | Change | Change (%) | Open | High | Low |
|---|
News
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AstraZeneca PLC- AZN | Morningstar
North American Morning Briefing: Nasdaq Futures Slip on AI Anxiety | Morningstar
Tlwm Makes New $1.76 Million Investment in Astrazeneca Plc $AZN
AstraZeneca may buck a decade of pharma strategy to buy U.S. scale
180 Wealth Advisors LLC Invests $3.89 Million in Astrazeneca Plc $AZN
High-Stakes 100-Billion-Yuan Mega Investment Gamble Unfolds: What's Next for the Trillion-Scale Economic Bet?
AstraZeneca and Bristol Myers Squibb: No Ongoing Merger Discussions Confirmed, ETPharma
AstraZeneca, Jaguar Land Rover join UK push to lure talent away from US
AstraZeneca's (AZN) "Buy" Rating Reiterated at Jefferies Financial Group - Daily Political
Astrazeneca (NYSE:AZN) Sees Large Volume Increase - Here's What Happened
SOPHiA GENETICS (NASDAQ:SOPH) Hits New 52-Week High After Analyst Upgrade - Markets Daily
SOPHiA GENETICS (NASDAQ:SOPH) Reaches New 1-Year High After Analyst Upgrade - Zolmax
AstraZeneca and Bristol Myers Squibb merger talks denied
Astrazeneca Plc (NYSE:AZN) Plans Dividend of GBP 0.80
Exclusive-'No discussions' over AstraZeneca-Bristol Myers deal, senior source says
BTIG Research Issues Positive Forecast for SOPHiA GENETICS (NASDAQ:SOPH) Stock Price - Zolmax
Deutsche Bank Aktiengesellschaft Reiterates Sell Rating for AstraZeneca (LON:AZN) - Daily Political
Harvard Student Consultants Log 400 Hours and Party With Snakes
Astrazeneca Plc (AZN) to Issue Dividend of GBP 0.80 on September 8th - Daily Political
SOPHiA GENETICS (NASDAQ:SOPH) Price Target Raised to $9.00 at BTIG Research - Daily Political
Eastern Bank Purchases Shares of 6,092 Astrazeneca Plc $AZN - Daily Political
Integrating clinically actionable biomarkers into bladder cancer care - recommendations from the International Bladder Cancer Group
AstraZeneca-BMY megadeal talk sparks huge market rift
SOPH Stock Heads For Best Day In Over 8 Months - What's Driving Today's Super Rally?
Brokers split on AstraZeneca merger talk as shares recover some ground
Most big businesses bought zero new petrol or diesel cars for their fleets last year, report reveals
SOPHiA GENETICS Collaborates With AstraZeneca To Develop Precision Oncology Companion Diagnostics
Hilltop National Bank Invests $1.44 Million in Astrazeneca Plc $AZN
Pharmaceutical Stocks Worth Watching - August 4th - Daily Political
Hilltop National Bank Buys Shares of 7,577 Astrazeneca Plc $AZN - Stock Observer
Why Did AMZN, SNOW, BMY Stocks Surge To 52-Week Highs Today?
UK's AstraZeneca eyeing $400b merger, report says - World - Chinadaily.com.cn
Navigating evidence-based recommendations for the management of systemic sclerosis
International Business: AstraZeneca shares fall on merger talks
Advances in the treatment of eosinophilic granulomatosis with polyangiitis
European shares start August higher on US-Iran diplomacy hopes
Amazon joins US$3t market cap club as cheaper oil buoys market
The $400 Billion Reason Bristol-Myers Squibb (BMY) Stock Is Up Today
AstraZeneca Stock Plunges 7.7% on Reported $400 Billion Merger Talks
Top Healthcare Analyst: A $400 Billion AstraZeneca-Bristol Myers Deal Could "Cut Costs in a Big Way"
Astrazeneca (NYSE:AZN) Shares Gap Down - Should You Sell? - Markets Daily
Stocks mixed as AstraZeneca merger talk dents FTSE 100
AstraZeneca shares slump after $400bn BMS merger rumours
Investors Buy Large Volume of Call Options on Astrazeneca (NYSE:AZN)
AstraZeneca Slides 8% On Report Of Potential Bristol Myers Merger Talks
AstraZeneca and Bristol-Myers Squibb: Megamerger Reports Leave Us Scratching Our Heads | Morningstar
AstraZeneca (LON:AZN) Stock Price Down 9% - Time to Sell? - Stock Observer
Execs hail 'merger of equals' in Supernus, Indivior deal
AstraZeneca Down Nearly 8%, on Pace for Largest Percent Decrease Since April 2025 - Data Talk | Morningstar
Compugen Q2 Earnings Call Highlights - Zolmax
Bristol Myers Squibb Stock Jumps on Reported Merger Talks With AstraZeneca
Manufacturing Stocks To Add to Your Watchlist - August 3rd - Stock Observer
An AstraZeneca, Bristol Myers Squibb merger could create a cancer-drug giant, but analysts call it 'odd' | Morningstar
Astrazeneca (NYSE:AZN) Shares Gap Down - Here's Why - Stock Observer
A $400 Billion Pharma Deal Could Get Really Messy: Chris Hughes
An AstraZeneca-Bristol Myers megamerger? Wall Street isn't thrilled.
AstraZeneca Weighs a Deal Its CEO Said It Didn't Need
Report: AstraZeneca explores tie-up with Bristol Myers Squibb
Dow Jones Top Company Headlines at 7 AM ET: AstraZeneca Shares Drop, Bristol Myers Squibb's Climb After Merger Talks Reports | Banco ... | Morningstar
AstraZeneca reported tie-up talks with Bristol-Myers Squibb are moving stocks. Analysts are puzzled. | Morningstar
AstraZeneca Investors See Little Logic in Bristol-Myers Tie-Up
AstraZeneca shares sink 7% on report of historic $400 billion merger talks with Bristol Myers Squibb
North American Morning Briefing: Stock Futures Up, Oil Slumps After Trump Calls Off Iran Attack | Morningstar
AstraZeneca Shares Drop, Bristol Myers Squibb's Climb After Merger Talks Reports - Update | Morningstar
Rathbones Group PLC Has $1.56 Billion Stock Holdings in Astrazeneca Plc $AZN - Markets Daily
European Midday Briefing: Shares Rise, Oil Tumbles on Renewed U.S.-Iran Diplomacy | Morningstar
AstraZeneca Shares Sink 7% As Bristol Myers Merger Talks Spark...
AstraZeneca shares drop on reports of $570b mega-merger
| Country News
AstraZeneca Shares Drop After Reports of Bristol Myers Squibb Merger Talks | Morningstar
Bristol Myers Squibb (BMY) In Early Merger Talks With AstraZeneca
AstraZeneca shares tumble 7% after reported Bristol Myers talks
AstraZeneca shares drop 7% after report on $400 billion merger talks with Bristol Myers Squibb
AstraZeneca in talks over £300bn mega-merger with US rival - reports
AstraZeneca Held Talks to Combine With Bristol Myers Squibb, FT Says, Citing Sources | Morningstar
AstraZeneca and Bristol Myers Squibb Explore $400 Billion Merger Talks, ETPharma
AstraZeneca And Bristol Myers Reportedly In Talks On $400 Bln Deal
Biotech Stocks Need A Shot In The Arm After Brutal July: Could AstraZeneca-Bristol Myers Megadeal Be The Cure?
Astrazeneca Plc (NYSE:AZN) Given Consensus Rating of "Moderate Buy" by Analysts - Daily Political
AstraZeneca in discussions to combine with Bristol Myers for $400B, FT says
The next generation of antibody-drug conjugates
AstraZeneca holds talks with Bristol Myers Squibb on $400 billion megadeal, FT reports
AstraZeneca holds talks with Bristol Myers Squibb on US$400 billion megadeal
AstraZeneca held talks with Bristol Myers Squibb on US$400 billion megadeal: source
AstraZeneca holds talks with Bristol Myers Squibb on $400B megadeal: report
AstraZeneca and Bristol-Myers Squibb in talks over potential merger - Report
AstraZeneca plots £300bn tie-up with US rival
AstraZeneca holds talks with Bristol Myers Squibb on potential megadeal, report says
AstraZeneca in talks with Bristol Myers Squibb on $400 billion megadeal, FT reports
AstraZeneca, Bristol Myers Squibb Held Talks for Tie-Up, FT Says
Henshaw Capital LLC Cuts Holdings in Astrazeneca Plc $AZN - Markets Daily
Astrazeneca Plc $AZN Shares Sold by NWI Management LP
Centaurus Financial Inc. Lowers Stock Position in Astrazeneca Plc $AZN - Daily Political
Astrazeneca (NYSE:AZN) Rating Lowered to "Hold" at Wall Street Zen
AstraZeneca News
S&P 500 Forecast and Predictions for 2026, 2027 and 2030, Can US Stocks Find a Second Wind?
Broadcom (AVGO) Stock Forecast 2026–2030: Can AI Growth Drive Further Gains?
Broadcom AVGO Stock Analysis 2026: Can AI Growth Justify the Price?
Morning Report:Middle east tensions ease, US jobs on the lookout
Latest news
Show more
Gold Price Today, August 7: XAU/USD Holds Near $4,250 Before US Jobs Report
Western Digital Stock Falls 13% and Sandisk Slides 7% as Guidance Disappoints
SpaceX Stock Jumps 6% on $100 Billion Unlock Day as Earlier Selloff Absorbs Supply Shock
Alphabet Stock Falls as AI Leadership Changes and $25 Billion Bond Sale Raise Spending Questions
AVGO Stock News Today: Broadcom Gains as AI Chip Momentum and September Earnings Move Into Focus
